1. Lyu X, Zhao Q, Hui J, Wang T, Lin M, Wang K, et al. The global landscape of approved antibody therapies. Antib Ther. 2022;5(4):233–57.
2. Walsh G, Walsh E. Biopharmaceutical benchmarks. Nat Biotechnol. 2022;2022:1–39.
3. Rathore AS, Chirmule N, Malani H. Reimagining affordable biosimilars. Biopharm Int. 2020;33(10):16–22.
4. Wang W, Roberts CJ. Protein aggregation—mechanisms, detection, and control. Int J Pharm. 2018;550(1–2):251–68.
5. Singla A, Bansal R, Joshi V, Rathore AS. Aggregation kinetics for IgG1-based monoclonal antibody therapeutics. AAPS J. 2016;18(3):689–702.